In November 2023, the Food and Drug Administration (FDA) approved Zepbound (tirzepatide) for long-term weight management ... They can also work with you to create a custom weight loss plan ...

The biotech has named Jamie Coleman its chief commercial officer, per a Monday announcement, putting her in charge of the ...

Popular Eli Lilly weight-loss drug Zepbound can be covered by Medicare plans to treat sleep apnea after it received Food and ...

Both of these GLP-1 drugs were originally designed for diabetes, but their benefits keep expanding — KSTP health expert Dr.

Zepbound is a medicine you can obtain only by prescription, and it's typically used to address obesity and other ...

A high dose of Novo Nordisk’s obesity drug Wegovy led patients to lose substantial weight in a clinical trial, but still less ...

The anti-obesity drug Zepbound made by Eli Lilly & Co. could ... without coverage depending on their dosage, some point to the long-term cost savings if obese Americans lose weight and avoid ...

Biopharma executives shared their thoughts on the potential impacts of the new administration; Annalee Armstrong recaps JPM ...

This helps Zepbound work effectively. Zepbound is used in combination with exercise and a low calorie diet. For full details about dosing, see this Zepbound dosage article. Zepbound is a ...

Lilly is considering expanding the availability of lower-priced vials of its blockbuster obesity drug Zepbound ...

On Dec. 26, the FDA officially declared the shortage over, a long-sought victory for Lilly. Lilly recorded $3 billion in sales from Zepbound in the first nine months of the year, according to a ...

Why it matters: Lilly's growth prospects are driven by Mounjaro and Zepbound, and shortfalls in sales could portend weaker long-term potential ... but they show their work, distinguish facts ...